• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SeqReporter:在临床实验室中自动化下一代测序结果解释和报告工作流程。

SeqReporter: automating next-generation sequencing result interpretation and reporting workflow in a clinical laboratory.

机构信息

Division of Molecular and Genomic Pathology, Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

Division of Molecular and Genomic Pathology, Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.

出版信息

J Mol Diagn. 2014 Jan;16(1):11-22. doi: 10.1016/j.jmoldx.2013.08.005. Epub 2013 Nov 9.

DOI:10.1016/j.jmoldx.2013.08.005
PMID:24220144
Abstract

A wide repertoire of bioinformatics applications exist for next-generation sequencing data analysis; however, certain requirements of the clinical molecular laboratory limit their use: i) comprehensive report generation, ii) compatibility with existing laboratory information systems and computer operating system, iii) knowledgebase development, iv) quality management, and v) data security. SeqReporter is a web-based application developed using ASP.NET framework version 4.0. The client-side was designed using HTML5, CSS3, and Javascript. The server-side processing (VB.NET) relied on interaction with a customized SQL server 2008 R2 database. Overall, 104 cases (1062 variant calls) were analyzed by SeqReporter. Each variant call was classified into one of five report levels: i) known clinical significance, ii) uncertain clinical significance, iii) pending pathologists' review, iv) synonymous and deep intronic, and v) platform and panel-specific sequence errors. SeqReporter correctly annotated and classified 99.9% (859 of 860) of sequence variants, including 68.7% synonymous single-nucleotide variants, 28.3% nonsynonymous single-nucleotide variants, 1.7% insertions, and 1.3% deletions. One variant of potential clinical significance was re-classified after pathologist review. Laboratory information system-compatible clinical reports were generated automatically. SeqReporter also facilitated quality management activities. SeqReporter is an example of a customized and well-designed informatics solution to optimize and automate the downstream analysis of clinical next-generation sequencing data. We propose it as a model that may envisage the development of a comprehensive clinical informatics solution.

摘要

生物信息学应用程序的广泛存在可用于下一代测序数据分析;然而,临床分子实验室的某些要求限制了它们的使用:i)全面的报告生成,ii)与现有实验室信息系统和计算机操作系统的兼容性,iii)知识库开发,iv)质量管理,和 v)数据安全。SeqReporter 是一个使用 ASP.NET 框架版本 4.0 开发的基于网络的应用程序。客户端使用 HTML5、CSS3 和 JavaScript 进行设计。服务器端处理(VB.NET)依赖于与自定义 SQL Server 2008 R2 数据库的交互。总的来说,SeqReporter 分析了 104 个案例(1062 个变异调用)。每个变异调用被分为以下五个报告级别之一:i)已知的临床意义,ii)不确定的临床意义,iii)等待病理学家审查,iv)同义和深内含子,和 v)平台和面板特异性序列错误。SeqReporter 正确注释和分类了 99.9%(860 个中的 859 个)的序列变体,包括 68.7%的同义单核苷酸变体、28.3%的非同义单核苷酸变体、1.7%的插入和 1.3%的缺失。经过病理学家审查后,一个具有潜在临床意义的变体被重新分类。与实验室信息系统兼容的临床报告自动生成。SeqReporter 还促进了质量管理活动。SeqReporter 是一个定制和精心设计的信息学解决方案的示例,用于优化和自动化临床下一代测序数据的下游分析。我们建议将其作为一个模型,可以设想开发一个全面的临床信息学解决方案。

相似文献

1
SeqReporter: automating next-generation sequencing result interpretation and reporting workflow in a clinical laboratory.SeqReporter:在临床实验室中自动化下一代测序结果解释和报告工作流程。
J Mol Diagn. 2014 Jan;16(1):11-22. doi: 10.1016/j.jmoldx.2013.08.005. Epub 2013 Nov 9.
2
Next-generation sequencing and its applications in molecular diagnostics.下一代测序及其在分子诊断中的应用。
Expert Rev Mol Diagn. 2011 Apr;11(3):333-43. doi: 10.1586/erm.11.3.
3
Next-generation sequencing - feasibility and practicality in haematology.下一代测序 - 在血液学中的可行性和实用性。
Br J Haematol. 2013 Mar;160(6):736-53. doi: 10.1111/bjh.12194. Epub 2013 Jan 7.
4
Analysis of next-generation sequencing data using Galaxy.使用Galaxy分析下一代测序数据。
Methods Mol Biol. 2014;1150:21-43. doi: 10.1007/978-1-4939-0512-6_2.
5
Next generation sequencing for TCR repertoire profiling: platform-specific features and correction algorithms.下一代测序技术用于 TCR 库谱分析:平台特异性特征和校正算法。
Eur J Immunol. 2012 Nov;42(11):3073-83. doi: 10.1002/eji.201242517. Epub 2012 Sep 24.
6
A user-friendly computational workflow for the analysis of microRNA deep sequencing data.一种用于分析微小RNA深度测序数据的用户友好型计算工作流程。
Methods Mol Biol. 2013;936:35-45. doi: 10.1007/978-1-62703-083-0_3.
7
Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss.下一代测序技术在遗传性听力损失分子诊断中的性能评估。
Otolaryngol Head Neck Surg. 2013 Jun;148(6):1007-16. doi: 10.1177/0194599813482294. Epub 2013 Mar 22.
8
Clinical genomics information management software linking cancer genome sequence and clinical decisions.临床基因组学信息管理软件将癌症基因组序列与临床决策联系起来。
Genomics. 2013 Sep;102(3):140-7. doi: 10.1016/j.ygeno.2013.04.007. Epub 2013 Apr 17.
9
E-probe Diagnostic Nucleic acid Analysis (EDNA): a theoretical approach for handling of next generation sequencing data for diagnostics.E 探针诊断核酸分析(EDNA):用于处理下一代测序数据进行诊断的理论方法。
J Microbiol Methods. 2013 Sep;94(3):356-66. doi: 10.1016/j.mimet.2013.07.002. Epub 2013 Jul 16.
10
College of American Pathologists' laboratory standards for next-generation sequencing clinical tests.美国病理学家学会下一代测序临床试验室标准。
Arch Pathol Lab Med. 2015 Apr;139(4):481-93. doi: 10.5858/arpa.2014-0250-CP. Epub 2014 Aug 25.

引用本文的文献

1
Mutation Detection in the Tumor Tissue from Selected Polish Patients with Breast Cancer Using Next Generation Sequencing.利用下一代测序技术对选定的波兰乳腺癌患者肿瘤组织进行突变检测。
Genes (Basel). 2021 Apr 2;12(4):519. doi: 10.3390/genes12040519.
2
Development and validation of Houston Methodist Variant Viewer version 3: updates to our application for interpretation of next-generation sequencing data.休斯顿卫理公会变异查看器3版本的开发与验证:我们用于解读下一代测序数据的应用程序更新
JAMIA Open. 2020 Mar 17;3(2):299-305. doi: 10.1093/jamiaopen/ooaa004. eCollection 2020 Jul.
3
System for Informatics in the Molecular Pathology Laboratory: An Open-Source End-to-End Solution for Next-Generation Sequencing Clinical Data Management.
分子病理学实验室信息系统:下一代测序临床数据管理的开源端到端解决方案。
J Mol Diagn. 2018 Jul;20(4):522-532. doi: 10.1016/j.jmoldx.2018.03.008. Epub 2018 Apr 24.
4
Epithelial-Myoepithelial Carcinoma: Frequent Morphologic and Molecular Evidence of Preexisting Pleomorphic Adenoma, Common HRAS Mutations in PLAG1-intact and HMGA2-intact Cases, and Occasional TP53, FBXW7, and SMARCB1 Alterations in High-grade Cases.上皮-肌上皮癌:常见的形态学及分子学证据显示其起源于多形性腺瘤,PLAG1和HMGA2未发生改变的病例中常见HRAS突变,高级别病例中偶见TP53、FBXW7及SMARCB1改变 。
Am J Surg Pathol. 2018 Jan;42(1):18-27. doi: 10.1097/PAS.0000000000000933.
5
Next-generation sequencing-based molecular characterization of primary urinary bladder adenocarcinoma.基于下一代测序的原发性膀胱腺癌的分子特征分析。
Mod Pathol. 2017 Aug;30(8):1133-1143. doi: 10.1038/modpathol.2017.33. Epub 2017 May 26.
6
PathOS: a decision support system for reporting high throughput sequencing of cancers in clinical diagnostic laboratories.PathOS:临床诊断实验室中用于报告癌症高通量测序结果的决策支持系统。
Genome Med. 2017 Apr 24;9(1):38. doi: 10.1186/s13073-017-0427-z.
7
Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis.甲状腺结节的分子特征:改善细针穿刺活检(FNAC)诊断的当前方法
Int J Mol Sci. 2017 Apr 6;18(4):775. doi: 10.3390/ijms18040775.
8
User-centered design of multi-gene sequencing panel reports for clinicians.以临床医生为中心的多基因测序面板报告设计。
J Biomed Inform. 2016 Oct;63:1-10. doi: 10.1016/j.jbi.2016.07.014. Epub 2016 Jul 14.
9
Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.根据多形性腺瘤的形态学证据、PLAG1 或 HMGA2 重排以及常见基因改变定义的涎腺导管癌亚型。
Cancer. 2016 Oct 15;122(20):3136-3144. doi: 10.1002/cncr.30179. Epub 2016 Jul 5.
10
Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer.甲状腺髓样癌驱动性ALK融合基因的鉴定及基因组图谱
PLoS Genet. 2015 Aug 21;11(8):e1005467. doi: 10.1371/journal.pgen.1005467. eCollection 2015 Aug.